PSI Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-700
Closed 741
2025
Q1
$0 Hold
700
﹤0.01% 960
2024
Q4
$0 Hold
700
﹤0.01% 921
2024
Q3
$13 Hold
700
﹤0.01% 886
2024
Q2
$75 Buy
+700
New +$335 ﹤0.01% 854
2024
Q1
Sell
-700
Closed -$1.23K 868
2023
Q4
$1.23K Sell
700
-495
-41% -$723 ﹤0.01% 748
2023
Q3
$1.72K Buy
1,195
+140
+13% +$350 ﹤0.01% 694
2023
Q2
$2.74K Hold
1,055
﹤0.01% 642
2023
Q1
$3.88K Hold
1,055
﹤0.01% 560
2022
Q4
$1.87K Sell
1,055
-300
-22% -$798 ﹤0.01% 613
2022
Q3
$6K Hold
1,355
﹤0.01% 510
2022
Q2
$8K Buy
1,355
+700
+107% +$5.73K ﹤0.01% 515
2022
Q1
$10K Sell
655
-700
-52% -$9.37K ﹤0.01% 476
2021
Q4
$21K Buy
1,355
+185
+16% +$4.44K 0.01% 396
2021
Q3
$37K Buy
+1,170
New +$41.1K 0.02% 314

Other funds holding DMTK

PSI Advisors's DMTK Position: Q2 2025 in Review

PSI Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2025, closing a stake of 700 shares.

PSI Advisors first reported a position in DMTK in Q3 2021 and held it in 14 quarters. The position peaked at $37K in Q3 2021. 2 funds tracked by Wall St. Rank hold DMTK as of Q2 2025.

  • PSI Advisors reported no remaining DermTech, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • PSI Advisors sold 700 DermTech, Inc. Common Stock shares in Q2 2025.
  • PSI Advisors first reported a position in DermTech, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • PSI Advisors's DermTech, Inc. Common Stock position peaked at $37K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2025.

Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.